Trials / Unknown
UnknownNCT04332705
Cryptosporidium Infection and Human Colorectal Cancer
Role of the Protozoa Cryptosporidium in the Development of Colorectal Cancer in Humans
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 324 (estimated)
- Sponsor
- Lille Catholic University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
It has been reported that Cryptosporidium parvum, a species of a protozoan frequently isolated from humans and animals, is able to induce digestive adenocarcinoma in a rodent model. Consistently, some epidemiological studies have reported an association with cryptosporidiosis in patients with colorectal adenocarcinoma. However, the correlation between cryptosporidiosis and human digestive cancer remains unclear at this time, and it is not known whether this intracellular parasite, considered an opportunistic agent, is able to induce gastrointestinal malignancies in humans. In order to add new arguments for a probable association between cryptosporidiosis and digestive human cancer, the main aim of this study is to determine prevalence and to identify species of Cryptosporidium among a French digestive cancer population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Detection of Cryptosporidium infection | A biopsy or a surgical sample will be collected from every participant |
Timeline
- Start date
- 2020-06-30
- Primary completion
- 2024-06-30
- Completion
- 2024-12-30
- First posted
- 2020-04-03
- Last updated
- 2023-11-18
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04332705. Inclusion in this directory is not an endorsement.